Molecules, Medicines, and Markets (BIO-0127)
Spring 2027 · BIO 0127 · Tufts University · 3 credits · Undergraduate
How biotechnology and pharmaceutical companies develop new drugs, from target identification and validation through preclinical optimization and testing, clinical trials, regulatory approval, and commercialization. Additional topics include R&D decision-making by drug developers and investors and the impact of new and emerging technologies, economic factors, and government policies on drug development. Prerequisites: BIO 14, 41, and at least one BIO course numbered above 41; or graduate standing in Biology; or instructor consent.
Course codes: BIO-0127, BIO 0127, BIO0127, BIO-127, BIO 127, BIO127
- 01-LEC (Lecture) — Frank Samuel David